Boston Scientific (BSX)

R&D to Revenue

10.18%

Quarterly · Period ending:

BSX logo

BSX R&D to Revenue

Latest reported10.18%
BSX Quarterly R&D/Revenue (0.00% → 10.18%)
High-resolution chart · PNG

BSX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific R&D to Revenue — Quarterly
Period endingR&D to Revenue
10.5655%
8.5627%
8.3072%
7.362%
7.0504%
7.2165%
7.113%
6.9465%
6.7493%
6.9209%
108.3077%
8.6375%
9.6104%
9.4894%
14.923%
9.1196%
8.6553%
8.4419%
0%
8.1081%
8.0347%
8.0025%
0%
7.5172%
7.2151%
7.325%
6.0033%
6.4171%
6.9154%
7.1225%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.